0

Global Lennox-Gastaut Syndrome Treatment Market 2019-2023

  • Published: Mar 2019
  • Pages: 116
  • SKU: IRTNTR31048
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global Lennox-Gastaut syndrome treatment market size will grow by USD 610 million during 2019-2023. This report provides a detailed analysis of the market by type (non-surgical treatment and surgical treatment) and geography (Asia, Europe, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several Lennox-Gastaut syndrome treatment companies including Eisai Co., Ltd., GlaxoSmithKline plc., H. Lundbeck A/S, Johnson & Johnson Services, Inc., and Supernus Pharmaceuticals, Inc.

Some of the key findings from our Lennox-Gastaut syndrome treatment market forecast report are summarized below

Global Lennox-Gastaut Syndrome Treatment Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Lennox-Gastaut syndrome treatment industry overview

Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.

The identification and treatment of LGS in the early stages is necessary as it may have life-threatening consequences in pediatric patients. Moreover, LGS is a rare disease which requires greater awareness among people for early diagnosis and treatment. Several governmental and non-governmental organizations such as Genetic and Rare Diseases (GARD) Information Center, National Organization of Rare Disorders (NORD), Epilepsy Society, and Genetic Alliance Australia are educating people and providing medical care and support to LGS patients. These organizations are raising awareness about the signs, symptoms, diagnosis, and treatment of LGS. This growing awareness of LGS will subsequently boost the demand for Lennox-Gastaut syndrome treatment driving market growth at a CAGR of almost 5% during the forecast period.

Top Lennox-Gastaut syndrome treatment companies covered in this market research report

The global Lennox-Gastaut syndrome treatment market is moderately fragmented. To help clients improve their market position, this report provides an analysis of the market's competitive landscape and offers information on the products offered by various companies. Moreover, this Lennox-Gastaut syndrome treatment market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading companies including:

  • Eisai Co., Ltd.
  • GlaxoSmithKline plc.
  • H. Lundbeck A/S
  • Johnson & Johnson Services, Inc.
  • Supernus Pharmaceuticals, Inc

Lennox-Gastaut syndrome treatment market segmentation based on the type

  • Non-surgical treatment
  • Surgical treatment

The non-surgical treatment segment will account for the highest Lennox-Gastaut syndrome treatment market share because of the recent LGS drug approvals and the adoption of ketogenic diet. This report provides an accurate prediction of the contribution of all the segments to the growth of the Lennox-Gastaut syndrome treatment market size.

Lennox-Gastaut syndrome treatment market segmentation based on geographic region

  • Asia
  • Europe
  • North America
  • ROW

With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the Lennox-Gastaut syndrome treatment market throughout the forecast period. The rising awareness of LGS, increasing investments in research on LGS, and strategic alliances among companies will drive LGS market growth in this region.

Key highlights of the global Lennox-Gastaut syndrome treatment market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the Lennox-Gastaut syndrome treatment market during the next five years
  • Precise estimation of the global Lennox-Gastaut syndrome treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the Lennox-Gastaut syndrome treatment industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on several vendors
  • Comprehensive details of factors that will challenge the growth of Lennox-Gastaut syndrome treatment companies  

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Non-surgical treatment - Market size and forecast 2018-2023
  • Surgical treatment - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc.
  • H. Lundbeck A/S
  • Johnson & Johnson Services, Inc.
  • Supernus Pharmaceuticals, Inc

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>